During the last few years, numerous innovative agents have been discovered as a result of tremendous developments in the understanding of the molecular basis of cancer. Further clinical progress in cancer treatment will be accomplished mainly through the conduct of translational research projects, efficient new drug development and the execution of large, prospective, randomised, multicentre cancer clinical trials. This requires a joint and global approach, and early and optimal exchange of information. For these reasons, the Symposium has been organised to ensure the maximum amount of interaction and discussion through an exciting range of plenary sessions and lively workshops.

Plenary Sessions:

1. Changing Landscape of Clinical Trial Design: Small Studies, Large Differences
2. Proffered Paper Session
3. Biomarkers for Antitumour Evaluation
4. Next Generation Gene Sequencing: how to use?
5. Drug Dosing
6. Proffered Paper Session
7. Microenvironment
8. Drug Resistance in Targeted Agents

http://www.informed-scientist.org/congress/24th-eortc-nci-aacr-symposium-on-molecular-targets-and-cancer-therapeutics